Клиническая онкогематология. Фундаментальные исследования и клиническая практика
Clinical Oncohematology. Basic Research and Clinical Practice
ISSN 1997-6933 (print)
ISSN 2500-2139 (online)
Русский English
  • Register
  • Login
Skip to main content Skip to main navigation menu Skip to site footer
Clinical Oncohematology
Basic Research and Clinical Practice

ИФ РИНЦ:     0,587
H-INDEX:        16

  • Home
  • About the Journal
    • Aims and Scope
    • Editorial Masthead
    • Peer Review
    • Publishing Ethics and Malpractice Statement
    • Indexing and Abstracting
    • Ownership, management and funding
    • Open Access Policy and Publication Fee
  • Articles
    • Current
    • Journal pre-proofs
    • Archive
    • SUPPLEMENT
  • Sections
    • LYMPHOID TUMORS
    • MYELOID TUMORS
    • BONE MARROW TRANSPLANTATION
    • ANEMIAS
    • AUTOIMMUNE DISEASES
    • CLINICAL TRIALS
    • NOVEL CORONAVIRUS INFECTION
    • NEWS
    • NEW TECHNOLOGIES
    • REVIEWS
    • COMPLICATIONS OF CHEMOTHERAPY
    • PRACTICAL RECOMMENDATIONS
    • RARE HEMATOLOGICAL TUMORS AND SYNDROMES
    • EXPERIMENTAL STUDIES
  • Submission
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Intermediate Results of Prospective, Randomized, Comparative Study of NHL BFM-90 and СНОЕР Efficacy in Primary ALK-Positive Anaplastic Large-Cell Lymphoma

    Liliya Gamilevna Gorenkova, S.K. Kravchenko, E.E. Klebanova, A.M. Kovrigina, K.A. Sychevskaya, E.G. Gemdzhian, E.S. Nesterova, Ya.K. Mangasarova, A.V. Misyurin, Yu.V. Sidorova, T.N. Obukhova
    382-388
    01.10.2020
  • Comorbidity and Personalized Treatment of Multiple Myeloma in Real Clinical Practice

    Nataliya Valer’evna Skvortsova, I.B. Kovynev, K.V. Khalzov, T.I. Pospelova, I.N. Nechunaeva
    322-334
    01.07.2020
  • Early Response and Long-Term Outcomes of Ruxolitinib Therapy in Myelofibrosis: Multicenter Retrospective Study in 10 Centers of the Russian Federation

    E.G. Lomaia, Nadiya Tamazovna Siordiya, O.M. Senderova, O.E. Ochirova, E.B. Zhalsanova, A.Yu. Furtovskaya, G.P. Dimov, M. G. Pozina, O.Yu. Li, K.B. Trizna, M.A. Mikhalev, E.V. Sokurova, A.A. Otmorskaya, A.S. Khazieva, V.V. Ust’yantseva, Yu.D. Rogovaya, A.Yu. Zaritskey
    335-345
    01.07.2020
  • Long-Term Outcomes of Nivolumab Therapy in Patients with Relapsed/Refractory Classic Hodgkin’s Lymphoma after High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Real Clinical Practice

    Kirill Viktorovich Lepik, N.P. Volkov, N.B. Mikhailova, E.V. Kondakova, L.A. Tsvetkova, Yu.R. Zalyalov, E.E. Lepik, L.V. Fedorova, A.V. Beinarovich, M.V. Demchenkova, O.G. Smykova, P.V. Kotselyabina, I.S. Moiseev, V.V. Baikov, B.V. Afanasyev
    280-288
    01.07.2020
  • Safety and Efficacy of BeEAC as a Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Lymphomas

    V.O. Sarzhevskii, Anastasiya Aleksandrovna Samoilova, V.Ya. Melnichenko, Yu.N. Dubinina, N.E. Mochkin, D.S. Kolesnikova, D.A. Fedorenko, E.G. Smirnova, A.E. Bannikova, V.S. Bogatyrev
    185-192
    01.04.2020
  • Bendamustine in the Treatment of Relapsed/Refractory Hodgkin’s Lymphoma: Literature Review and Clinical Experience

    Stanislav Sergeevich Shklyaev, N.A. Falaleeva, T.I. Bogatyreva, A.Yu. Terekhova, M.A. Danilova
    136-149
    01.04.2020
  • Prognostic Value of Next-Generation Sequencing Data in Patients with Myelodysplastic Syndrome

    Nikolai Yur’evich Tsvetkov, E.V. Morozova, I.M. Barkhatov, I.S. Moiseev, M.V. Barabanshchikova, A.V. Tishkov, D.S. Bug, N.V. Petukhova, E.A. Izmailova, S.N. Bondarenko, B.V. Afanasyev
    170-175
    01.04.2020
  • Chronic Myeloid Leukemia: Role of Allogeneic Hematopoietic Stem Cell Transplantation in the Era of Tyrosine Kinase Inhibitors

    Elena Vladislavovna Morozova, Yu.Yu. Vlasova, M.V. Barabanshchikova, N.N. Mamaev, I.M. Barkhatov, A.L. Alyanskii, E.I. Darskaya, M.V. Vladovskaya, S.N. Bondarenko, I.S. Moiseev, B.V. Afanasyev
    193-198
    01.04.2020
  • Clinical Efficacy of Daratumumab in Monotherapy of Relapsed/Refractory Multiple Myeloma

    Stanislav Semenovich Bessmeltsev, E.V. Karyagina, E.Yu. Ilyushkina, Zh.L. Stolypina, R.R. Miftakhova, I.I. Kostroma, T.L. Shelkovskaya
    25-32
    01.01.2020
  • Primary Bone Lymphomas: 18F-FDG PET and PET-CT as Methods of Diagnosis and Efficacy Estimation of Antitumor Treatment

    Anna Konstantinovna Smol’yaninova, E.R. Moskalets, G.A. Yatsyk, I.E. Kostina, A.S. Bogolyubskaya, N.G. Gabeeva, E.G. Gemdzhian, S.A. Tatarnikova, D.S. Badmadzhapova, E.E. Zvonkov
    33-49
    01.01.2020
  • Hodgkin’s Lymphoma: Analysis Results of Volgograd Regional Registry

    Kamil Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova, E.G. Gemdzhian
    363-376
    01.10.2019
  • Immunohistochemical Subtype and Parameters of International Prognostic Index in the New Prognostic Model of Diffuse Large B-Cell Lymphoma

    S.V. Samarina, A.S. Luchinin, N.V. Minaeva, I.V. Paramonov, D.A. D’yakonov, E.V. Vaneeva, V.A. Rosin, S.V. Gritsaev
    385-390
    01.10.2019
  • Expression of Adhesion Molecule CD56 in Tumor Plasma Cells in Bone Marrow as a Prognostic Factor in Multiple Myeloma

    Maiya Valer’evna Firsova, L.P. Mendeleeva, A.M. Kovrigina, M.V. Solov’ev, N.L. Deineko, M.Yu. Drokov, V.G. Savchenko
    377-384
    01.10.2019
  • Current Genetic Models for Prediction of Primary Myelofibrosis

    Lyubov Borisovna Polushkina, V.A. Shuvaev, M.S. Fominykh, Yu.A. Krivolapov, E.A. Belyakova, Z.P. Asaulenko, E.V. Motyko, L.S. Martynenko, M.P. Bakai, N.Yu. Tsybakova, S.V. Voloshin, S.S. Bessmeltsev, A.V. Chechetkin, I.S. Martynkevich
    391-397
    01.10.2019
  • Infectious Complications after Haploidentical Hematopoietic Stem Cells Transplantation in Patients with High-Risk Tumors of Hematopoietic and Lymphoid Tissues: A Single-Center Experience

    Yurii Sergeevich Osipov, S.S. Bessmeltsev, G.N. Salogub, V.V. Ivanov, E.S. Mikhailov, N.A. Zhukova, A.V. Chechetkin
    406-415
    01.10.2019
  • The Effect of Anticoagulant Therapy on Survival and Outcome of Venous Thrombosis in Children, Teenagers, and Young Adults with Acute Lymphoblastic Leukemia Treated According to ALL-MB-2008 and ALL-MB-2015 Protocols

    Vyacheslav Vasil’evich Dmitriev, N.V. Migal, O.I. Bydanov, N.V. Lipai, E.V. Dmitriev
    338-343
    01.07.2019
  • Primary Bone Lymphomas: Long-Term Results of a Prospective Single-Center Trial

    Anna Konstantinovna Smol’yaninova, N.G. Gabeeva, V.E. Mamonov, S.A. Tatarnikova, L.G. Gorenkova, D.S. Badmadzhapova, A.M. Kovrigina, E.G. Gemdzhian, E.E. Zvonkov
    247-262
    01.07.2019
  • Experience with the Use of Thio/Mel Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

    S.V. Gritsaev, Ivan Ivanovich Kostroma, A.A. Zhernyakova, I.M. Zapreeva, E.V. Karyagina, Zh.V. Chubukina, S.A. Tiranova, I.S. Martynkevich, S.S. Bessmeltsev, A.V. Chechetkin
    282-288
    01.07.2019
  • Prediction of FLAG ± Ida Regimen Efficacy in Patients with Relapsed/Refractory Acute Myeloid Leukemia

    Irina Garmaevna Budaeva, E.G. Ovsyannikova, E.N. Goryunova, O.V. Kulemina, D.V. Zaitsev, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, K.V. Bogdanov, O.S. Pisotskaya, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskey, L.L. Girshova
    289-296
    01.07.2019
  • TP53 Gene Mutations in Tumor Cells of Patients with Aggressive B-Cell Lymphomas

    Anna Evgen’evna Misyurina, S.K. Kravchenko, V.A. Misyurin, A.M. Kovrigina, A.U. Magomedova, E.A. Baryakh, F.E. Babaeva, A.V. Misyurin
    263-270
    01.07.2019
  • Clinical Value of miR-3151 Overexpression in Synergistic Interaction with BAALC Host Gene in Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

    Alena Igorevna Shakirova, I.M. Barkhatov, A.I. Churkina, N.N. Mamaev, L.S. Zubarovskaya, B.V. Afanas’ev
    303-308
    01.07.2019
  • Analysis Results of the Regional Registry of Patients with Diffuse Large B-cell Lymphoma: Risk Factors and Chemo-Immunotherapy Issues

    Kamil’ Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova, E.G. Gemdzhian, D.S. Abramov, D.M. Konovalov, G.L. Snigur, N.A. Red’kina
    154-164
    01.04.2019
  • Prognostic Value of PRAME Activity in Tumor Cells of Follicular Lymphoma

    Vsevolod Andreevich Misyurin, A.E. Misyurina, S.K. Kravchenko, N.A. Lyzhko, Yu.P. Finashutina, N.N. Kasatkina, D.S. Mar’in, E.S. Nesterova, N.N. Sharkunov, M.A. Baryshnikova, A.V. Misyurin
    173-178
    01.04.2019
  • Clinical Efficacy of Chelation Therapy in Patients with Low-Risk Myelodysplastic Syndrome

    Sergei Vasil’evich Gritsaev, I.I. Kostroma, A.A. Zhernyakova
    120-124
    01.04.2019
  • Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Russian Multicenter Clinical Trial

    Sergei Nikolaevich Bondarenko, E.N. Parovichnikova, A.A. Maschan, O.Yu. Baranova, T.V. Shelekhova, V.A. Doronin, V.Ya. Mel’nichenko, K.D. Kaplanov, O.S. Uspenskaya, A.N. Sokolov, N.V. Myakova, I.S. Moiseev, I.V. Markova, E.I. Darskaya, A.G. Smirnova, T.A. Bykova, B.I. Ayubova, I.A. Samorodova, E.V. Babenko, I.M. Barkhatov, T.L. Gindina, A.D. Kulagin, B.V. Afanas’ev
    145-153
    01.04.2019
  • Intermediate Results of Prospective Observational Study: The 2-year Experience of Ibrutinib Therapy in Relapsed/Refractory Mantle Cell Lymphoma in Clinical Practice

    Vladimir Ivanovich Vorob’ev, V.A. Zherebtsova, E.I. Dubrovin, L.A. Bychenkova, Yu.B. Kochkareva, L.A. Mukha, V.L. Ivanova, N.K. Khuazheva, V.V. Ptushkin
    165-172
    01.04.2019
  • Prognostic Value of Genetic Mutations in Patients with Acute Myeloid Leukemias: Results of a Cooperative Study of Hematology Clinics of Saint Petersburg (Russia) and Charite Clinic (Germany)

    Ekaterina Vadimovna Motyko, O.V. Blau, L.B. Polushkina, L.S. Martynenko, M.P. Bakai, N.Yu. Tsybakova, Yu.S. Ruzhenkova, E.V. Kleina, N.B. Pavlenko, A.M. Radzhabova, E.V. Karyagina, O.S. Uspenskaya, S.V. Voloshin, A.V. Chechetkin, I.S. Martynkevich
    211-219
    01.04.2019
  • Overcoming Resistance in Relapsed Anaplastic Large-Cell Lymphoma, ALK-Positive (Literature Review and Clinical Experience)

    Yuliya Eikhenovna Vinogradova, N.G. Chernova
    179-184
    01.04.2019
  • Comparative Study of Mycophenolate Mofetil and Methotrexate in Graft-Versus-Host Disease Prophylaxis in Adult Recipients of Related and Unrelated Allo-HSCT

    Ivan Sergeevich Moiseev, Yu.A. Tarakanova, A.L. Alyanskii, E.V. Babenko, M.M. Kanunnikov, V.A. Dubkova, E.V. Morozova, E.I. Darskaya, O.A. Slesarchuk, A.D. Kulagin, S.N. Bondarenko, B.V. Afanas’ev
    43-50
    01.01.2019
  • Clinical and Hematological Predictors of Response to First-Line Therapy in Patients with Diffuse Large B-Cell Lymphoma

    Svetlana Valer’evna Samarina, E.L. Nazarova, N.V. Minaeva, E.N. Zotina, I.V. Paramonov, S.V. Gritsaev
    68-72
    01.01.2019
  • Prognostic Value of the PRAME Gene Expression in T-Cell Lymphoproliferative Disorders

    E.A. Penskaya, Vsevolod Andreevich Misyurin, A.E. Misyurina, S.K. Kravchenko, L.G. Gorenkova, L.V. Plastinina, V.V. Tikhonova, Yu.P. Finashutina, N.A. Lyzhko, N.N. Kasatkina, L.A. Kesaeva, O.N. Solopova, A.V. Misyurin
    73-78
    01.01.2019
  • Practical Aspects of the Use of Carfilzomib in Multiple Myeloma

    Sergei Vyacheslavovich Semochkin, G.N. Salogub, S.S. Bessmeltsev, K.D. Kaplanov
    21-31
    01.01.2019
  • Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Experience in Treating 131 Patients at a National Medical Research Center in Russia

    I.Z. Zavodnova, M.Yu. Kichigina, E.V. Paramonova, Yu.E. Ryabukhina, O.A. Kolomeitsev, O.P. Trofimova, N.V. Volkova, Yu.I. Pryamikova, N.V. Kokosadze, Gayane Sergeevna Tumyan
    59-67
    01.01.2019
  • Epidemiology of Multiple Myeloma in Novosibirsk (Siberian Federal District)

    Nataliya Valer’evna Skvortsova, T.I. Pospelova, I.B. Kovynev, G.S. Soldatova, I.N. Nechunaeva
    86-94
    01.01.2019
  • Preventive Use of Azacitidine in Patients with Acute Myeloid Leukemia after Haploidentical Allo-BMT

    R.Sh. Badaev, D.B. Zammoeva, L.L. Girshova, D.V. Babenetskaya, N.A. Il’ina, Yu.A. Alekseeva, A.Yu. Zaritskey, Dmitrii Vasil’evich Motorin
    37-42
    01.01.2019
  • Magnetic Resonance Imaging of Bone Marrow and its Results as a Criterion for Administration of Maintenance Therapy After Auto-HSCT in Multiple Myeloma Patients

    Maksim Valer’evich Solov’ev, L.P. Mendeleeva, G.A. Yatsyk, N.S. Lutsik, M.V. Firsova, E.G. Gemdzhian, V.G. Savchenko
    360-367
    01.10.2018
  • PD-1 Blockade with Nivolumab as a New Immunotherapy for Classical Hodgkin’s Lymphoma

    Elena Andreevna Demina
    213-219
    01.07.2018
  • Outcome of Classical Hodgkin’s Lymphoma Treatment Based on High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Experience in the NI Pirogov Russian National Medical Center of Surgery

    Nikita Evgen’evich Mochkin, V.O. Sarzhevskii, Yu.N. Dubinina, E.G. Smirnova, D.A. Fedorenko, A.E. Bannikova, D.S. Kolesnikova, V.S. Bogatyrev, N.M. Faddeev, V.Ya. Mel’nichenko
    234-240
    01.07.2018
  • Results of Molecular Monitoring in Posttransplant Period by Means of Series Investigation of WT1 Gene Expression in Patients with Acute Myeloid Leukemia

    Ya.V. Gudozhnikova, Nikolai Nikolaevich Mamaev, I.M. Barkhatov, V.A. Katerina, T.L. Gindina, A.I. Shakirova, S.N. Bondarenko, O.A. Slesarchuk, E.I. Darskaya, O.V. Paina, L.S. Zubarovskaya, B.V. Afanas’ev
    241-251
    01.07.2018
  • Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Diagnostics of Extramediastinal Lesions and Treatment Opportunities

    Yana Konstantinovna Mangasarova, A.U. Magomedova, A.M. Kovrigina, I.E. Kostina, E.S. Nesterova, L.G. Gorenkova, A.E. Misyurina, O.V. Margolin, S.K. Kravchenko
    220-226
    01.07.2018
81 - 120 of 186 items << < 1 2 3 4 5 > >> 

oa-antiplagiat

Антиплагиат

Make a Submission

Make a Submission

Banner ROHS

Russian Oncohematology Society

Indexing Databases

  • ISSN
  • cyberleninka cyberleninka
  • DOAJ
  • Web of Science
  • Scopus
  • Elsevier
  • CAS Source Index (CASSI)
  • NLM Catalog
  • British Library
  • РИНЦ
  • Science Index
  • SCImago
  • The European Library
  • Scholia
  • Journal Observatory
  • Scholar Google
  • IPR Smart
  • RSL
  • Ulrich's Serials Analysis System
  • ВИНИТИ
  • WorldCat
  • Research4Life
  • Lens
  • Mendeley
  • MIAR
  • OpenCitations
  • xueshu
  • OpenAlex
  • Scilit
  • Wikidata
  • na.neicon
  • Internet Archive scholar
  • ZDB catalogue
  • Keepers ISSN
  • RusMed
  • RCSI

Editor-in-Chief

Gayane Sepugovna Tumyan

ARCHIVE

2026
  • Issue 1 (2026)
2025
  • Issue 1 (2025)
  • Issue 2 (2025)
  • Issue 3 (2025)
  • Issue 4 (2025)
2024
  • Issue 1 (2024)
  • Issue 2 (2024)
  • Issue 3 (2024)
  • Issue 4 (2024)
2023
  • Issue 1 (2023)
  • Issue 2 (2023)
  • Issue 3 (2023)
  • Issue 4 (2023)
2022
  • Issue 1 (2022)
  • Issue 2 (2022)
  • Issue 3 (2022)
  • Issue 4 (2022)
2021
  • Issue 1 (2021)
  • Issue 2 (2021)
  • Issue 3 (2021)
  • Issue 4 (2021)
2020
  • Issue 1 (2020)
  • Issue 2 (2020)
  • Issue 3 (2020)
  • Issue 4 (2020)
2019
  • Issue 1 (2019)
  • Issue 2 (2019)
  • Issue 3 (2019)
  • Issue 4 (2019)
2018
  • Issue 1 (2018)
  • Issue 2 (2018)
  • Issue 3 (2018)
  • Issue 4 (2018)
2017
  • Issue 1 (2017)
  • Issue 2 (2017)
  • Issue 3 (2017)
  • Issue 4 (2017)
2016
  • Issue 1 (2016)
  • Issue 2 (2016)
  • Issue 3 (2016)
  • Issue 4 (2016)
2015
  • Issue 1 (2015)
  • Issue 2 (2015)
  • Issue 3 (2015)
  • Issue 4 (2015)
2014
  • Issue 1 (2014)
  • Issue 2 (2014)
  • Issue 3 (2014)
  • Issue 4 (2014)
2013
  • Issue 1 (2013)
  • Issue 2 (2013)
  • Issue 3 (2013)
  • Issue 4 (2013)
ALL ARCHIVE

Keywords

Most Read Articles
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2024)
    3391
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)
    1273
  • Phase 3 Clinical Trial of 300 mg Vamotinib Directly Compared with High-Dose Imatinib in Chronic Myeloid Leukemia Patients in Chronic Phase with Failure of Standard-Dose Imatinib: Interim Analysis
    889
  • Multiple myeloma (pathogenesis, clinical features, diagnosis, differential diagnosis). Part I
    847
  • Anemia of Chronic Diseases
    847

Partners

Roche
Novartis Pharma
AstraZeneca
AbbVie
Swedish Orphan Biovitrum / SOBI
Roche
Novartis Pharma
AstraZeneca
AbbVie
Swedish Orphan Biovitrum / SOBI

«PRACTICAL MEDICINE» LLC
115201, Moscow, 1st Kotlyakovsky Pereulok 3
Phone. +7 (495) 324-93-29
E-mail: org@bloodjournal.ru
medprint.ru


Copyright © Clinical Oncohematology. Basic Research and Clinical Practice 2026

Up